150 related articles for article (PubMed ID: 28719094)
1. Discovery and characterization of a novel tryptophan hydroxylase 1 inhibitor as a prodrug.
Shi H; Cui Y; Qin Y
Chem Biol Drug Des; 2018 Jan; 91(1):202-212. PubMed ID: 28719094
[TBL] [Abstract][Full Text] [Related]
2. Analgesic effects of electroacupuncture at ST25 and CV12 in a rat model of postinflammatory irritable bowel syndrome visceral pain.
Zhu X; Liu Z; Qin Y; Niu W; Wang Q; Li L; Zhou J
Acupunct Med; 2018 Aug; 36(4):240-246. PubMed ID: 29720377
[TBL] [Abstract][Full Text] [Related]
3. Peripheral Serotonin Synthesis as a New Drug Target.
Matthes S; Bader M
Trends Pharmacol Sci; 2018 Jun; 39(6):560-572. PubMed ID: 29628275
[TBL] [Abstract][Full Text] [Related]
4. Optimization of spirocyclic proline tryptophan hydroxylase-1 inhibitors.
Goldberg DR; De Lombaert S; Aiello R; Bourassa P; Barucci N; Zhang Q; Paralkar V; Stein AJ; Holt M; Valentine J; Zavadoski W
Bioorg Med Chem Lett; 2017 Feb; 27(3):413-419. PubMed ID: 28041831
[TBL] [Abstract][Full Text] [Related]
5. Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract.
Liu Q; Yang Q; Sun W; Vogel P; Heydorn W; Yu XQ; Hu Z; Yu W; Jonas B; Pineda R; Calderon-Gay V; Germann M; O'Neill E; Brommage R; Cullinan E; Platt K; Wilson A; Powell D; Sands A; Zambrowicz B; Shi ZC
J Pharmacol Exp Ther; 2008 Apr; 325(1):47-55. PubMed ID: 18192499
[TBL] [Abstract][Full Text] [Related]
6. Discovery and biological characterization of a novel scaffold for potent inhibitors of peripheral serotonin synthesis.
Betari N; Sahlholm K; Ishizuka Y; Teigen K; Haavik J
Future Med Chem; 2020 Aug; 12(16):1461-1474. PubMed ID: 32752885
[No Abstract] [Full Text] [Related]
7. Oridonin Alleviates Visceral Hyperalgesia in a Rat Model of Postinflammatory Irritable Bowel Syndrome: Role of Colonic Enterochromaffin Cell and Serotonin Availability.
Zang KH; Shao YY; Zuo X; Rao Z; Qin HY
J Med Food; 2016 Jun; 19(6):586-92. PubMed ID: 27111743
[TBL] [Abstract][Full Text] [Related]
8. Intracolonical administration of protease-activated receptor-2 agonists produced visceral hyperalgesia by up-regulating serotonin in the colon of rats.
Li Z; Zhang XJ; Xu HX; Sung JJ; Bian ZX
Eur J Pharmacol; 2009 Mar; 606(1-3):199-204. PubMed ID: 19374846
[TBL] [Abstract][Full Text] [Related]
9. Exendin-4, an analogue of glucagon-like peptide-1, attenuates hyperalgesia through serotonergic pathways in rats with neonatal colonic sensitivity.
Yang Y; Cui X; Chen Y; Wang Y; Li X; Lin L; Zhang H
J Physiol Pharmacol; 2014 Jun; 65(3):349-57. PubMed ID: 24930506
[TBL] [Abstract][Full Text] [Related]
10. Discovery of spirocyclic proline tryptophan hydroxylase-1 inhibitors.
Goldberg DR; De Lombaert S; Aiello R; Bourassa P; Barucci N; Zhang Q; Paralkar V; Valentine J; Zavadoski W
Bioorg Med Chem Lett; 2016 Feb; 26(4):1124-9. PubMed ID: 26821821
[TBL] [Abstract][Full Text] [Related]
11. Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disorders.
Shi ZC; Devasagayaraj A; Gu K; Jin H; Marinelli B; Samala L; Scott S; Stouch T; Tunoori A; Wang Y; Zang Y; Zhang C; Kimball SD; Main AJ; Sun W; Yang Q; Nouraldeen A; Yu XQ; Buxton E; Patel S; Nguyen N; Swaffield J; Powell DR; Wilson A; Liu Q
J Med Chem; 2008 Jul; 51(13):3684-7. PubMed ID: 18557609
[TBL] [Abstract][Full Text] [Related]
12. The ever-changing roles of serotonin.
Jones LA; Sun EW; Martin AM; Keating DJ
Int J Biochem Cell Biol; 2020 Aug; 125():105776. PubMed ID: 32479926
[TBL] [Abstract][Full Text] [Related]
13. Analgesic activity of cynaropicrinon on post-inflammatory irritable bowel syndrome visceral hypersensitivity in a rat model.
Shi H; Zhu X; Cui Y; Qin Y; Yang L; Deng X
Exp Ther Med; 2017 Nov; 14(5):4476-4482. PubMed ID: 29067122
[TBL] [Abstract][Full Text] [Related]
14. Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice.
Izikki M; Hanoun N; Marcos E; Savale L; Barlier-Mur AM; Saurini F; Eddahibi S; Hamon M; Adnot S
Am J Physiol Lung Cell Mol Physiol; 2007 Oct; 293(4):L1045-52. PubMed ID: 17675372
[TBL] [Abstract][Full Text] [Related]
15. Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension.
Aiello RJ; Bourassa PA; Zhang Q; Dubins J; Goldberg DR; De Lombaert S; Humbert M; Guignabert C; Cavasin MA; McKinsey TA; Paralkar V
J Pharmacol Exp Ther; 2017 Feb; 360(2):267-279. PubMed ID: 27927914
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid derivatives as bone anabolic agents targeted to tryptophan hydroxylase 1 (Tph-1).
Fu HJ; Zhao Y; Zhou YR; Bao BH; Du Y; Li JX
Eur J Pharm Sci; 2015 Aug; 76():33-47. PubMed ID: 25930119
[TBL] [Abstract][Full Text] [Related]
17. Isoform-Specific Substrate Inhibition Mechanism of Human Tryptophan Hydroxylase.
Tidemand KD; Peters GH; Harris P; Stensgaard E; Christensen HEM
Biochemistry; 2017 Nov; 56(46):6155-6164. PubMed ID: 29035515
[TBL] [Abstract][Full Text] [Related]
18. Nesfatin-1 in the dorsal raphe nucleus influences visceral sensitivity via 5-HT neurons in male maternally separated rats.
Zhang HA; Sang N; Ge X; Huang Q; Li XL; Sha J
Sci Rep; 2018 Jun; 8(1):9334. PubMed ID: 29921870
[TBL] [Abstract][Full Text] [Related]
19. p-ethynylphenylalanine: a potent inhibitor of tryptophan hydroxylase.
Stokes AH; Xu Y; Daunais JA; Tamir H; Gershon MD; Butkerait P; Kayser B; Altman J; Beck W; Vrana KE
J Neurochem; 2000 May; 74(5):2067-73. PubMed ID: 10800950
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of serotonin synthesis: A novel therapeutic paradigm.
Bader M
Pharmacol Ther; 2020 Jan; 205():107423. PubMed ID: 31629717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
